There were 18 articles covering the price reduction announcement and 59 syndicated articles in more than 10 countries

 

Top articles covering the announcement:

J&J, India's Lupin cut prices for tuberculosis drug in lower-income countries
GO URL
J&J cuts the price of its lifesaving TB pill by more than half for many low- and middle-income countries
GO URL
Cost of tuberculosis treatment halved in deal to permit generic versions
GO URL
About 450,000 people estimated to have drug-resistant TB globally
GO URL
Devex CheckUp: It’s raining deals
GO URL
How do we solve a problem like tuberculosis?
GO URL
Tuberculosis treatment is getting more affordable, offering hope to millions
GO URL
Stop TB’s Global Drug Facility Announces Historic Price Reductions Up To 55% For Bedaquiline, A Life-Saving Drug To Treat Drug-Resistant TB
GO URL
Johnson & Johnson slashes price of tuberculosis drug Sirturo after relinquishing patent protections
GO URL